Brimonidine

Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.

Product Specifications

CAS Number

[59803-98-4]

Product Name Alternative

UK 14304; AGN190342

UNSPSC

12352005

Hazard Statement

H301

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Endocrinology; Cancer; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/uk-14,304.html

Purity

99.98

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3

Molecular Formula

C11H10BrN5

Molecular Weight

292.13

Precautions

H301

References & Citations

[1]Andorn, A.C., M.A. Carlson, and R.C. Gilkeson, Specific [3H]UK 14,304 binding in human cortex occurs at multiple high affinity states with alpha 2-adrenergic selectivity and differing affinities for GTP. Life Sci, 1988. 43 (22) : p. 1805-12.|[2]Cambridge, D., UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes. Eur J Pharmacol, 1981. 72 (4) : p. 413-5.|[3]Chopin, P., F.C. Colpaert, and M. Marien, Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther, 1999. 288 (2) : p. 798-804.